메뉴 건너뛰기




Volumn 391, Issue 10117, 2018, Pages 219-229

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

(640)  Anand, Sonia S a,b   Bosch, Jackie a,c   Eikelboom, John W a,b   Connolly, Stuart J a,b   Diaz, Rafael d   Widimsky, Peter e   Aboyans, Victor f,ab   Alings, Marco g   Kakkar, Ajay K h   Keltai, Katalin i   Maggioni, Aldo P j   Lewis, Basil S k,ab   Störk, Stefan l   Zhu, Jun m   Lopez Jaramillo, Patricio n   O'Donnell, Martin o   Commerford, Patrick J p   Vinereanu, Dragos q   Pogosova, Nana r   Ryden, Lars s   more..


Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO; RIVAROXABAN; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 10A INHIBITOR;

EID: 85033579790     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(17)32409-1     Document Type: Article
Times cited : (713)

References (30)
  • 1
    • 33947533514 scopus 로고    scopus 로고
    • One-year cardiovascular event rates in outpatients with atherothrombosis
    • Steg, PG, Bhatt, DL, Wilson, PW, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 297 (2007), 1197–1206.
    • (2007) JAMA , vol.297 , pp. 1197-1206
    • Steg, P.G.1    Bhatt, D.L.2    Wilson, P.W.3
  • 2
    • 77956922384 scopus 로고    scopus 로고
    • Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis
    • Bhatt, DL, Eagle, KA, Ohman, EM, et al. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA 304 (2010), 1350–1357.
    • (2010) JAMA , vol.304 , pp. 1350-1357
    • Bhatt, D.L.1    Eagle, K.A.2    Ohman, E.M.3
  • 3
    • 79961106923 scopus 로고    scopus 로고
    • ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary
    • Brott, TG, Halperin, JL, Abbara, S, et al. ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary. Circulation 124 (2011), 489–532.
    • (2011) Circulation , vol.124 , pp. 489-532
    • Brott, T.G.1    Halperin, J.L.2    Abbara, S.3
  • 4
    • 85017378539 scopus 로고    scopus 로고
    • 2016 AHA/ACC Guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
    • Gerhard-Herman, MD, Gornik, HL, Barrett, C, et al. 2016 AHA/ACC Guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 135 (2017), e726–e779.
    • (2017) Circulation , vol.135 , pp. e726-e779
    • Gerhard-Herman, M.D.1    Gornik, H.L.2    Barrett, C.3
  • 5
    • 84856787115 scopus 로고    scopus 로고
    • Antithrombotic therapy in peripheral artery disease: antithrombotic therapy and prevention of thrombosis, 9th edn: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    • Alonso-Coello, P, Bellmunt, S, McGorrian, C, et al. Antithrombotic therapy in peripheral artery disease: antithrombotic therapy and prevention of thrombosis, 9th edn: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:suppl (2012), e669S–e690S.
    • (2012) Chest , vol.141 , pp. e669S-e690S
    • Alonso-Coello, P.1    Bellmunt, S.2    McGorrian, C.3
  • 6
    • 81855199782 scopus 로고    scopus 로고
    • ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC)
    • European Stroke Organisation, Tendera, M, Aboyans, V, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 32 (2011), 2851–2906.
    • (2011) Eur Heart J , vol.32 , pp. 2851-2906
    • Tendera, M.1    Aboyans, V.2
  • 7
    • 34447502152 scopus 로고    scopus 로고
    • Oral anticoagulant and antiplatelet therapy and peripheral arterial disease
    • Warfarin Antiplatelet Vascular Evaluation Trial Investigators, Anand, S, Yusuf, S, et al. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. N Engl J Med 357 (2007), 217–227.
    • (2007) N Engl J Med , vol.357 , pp. 217-227
    • Anand, S.1    Yusuf, S.2
  • 8
    • 0034728082 scopus 로고    scopus 로고
    • Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial
    • The Dutch Bypass Oral Anticoagulants or Aspirin Study Group. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial. Lancet 355 (2000), 346–351.
    • (2000) Lancet , vol.355 , pp. 346-351
  • 9
    • 85008318890 scopus 로고    scopus 로고
    • Ticagrelor versus clopidogrel in symptomatic peripheral artery disease
    • Hiatt, WR, Fowkes, FG, Heizer, G, et al. Ticagrelor versus clopidogrel in symptomatic peripheral artery disease. N Engl J Med 376 (2017), 32–40.
    • (2017) N Engl J Med , vol.376 , pp. 32-40
    • Hiatt, W.R.1    Fowkes, F.G.2    Heizer, G.3
  • 10
    • 33645861080 scopus 로고    scopus 로고
    • Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
    • Bhatt, DL, Fox, KA, Hacke, W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354 (2006), 1706–1717.
    • (2006) N Engl J Med , vol.354 , pp. 1706-1717
    • Bhatt, D.L.1    Fox, K.A.2    Hacke, W.3
  • 11
    • 58449114663 scopus 로고    scopus 로고
    • Patients with peripheral arterial disease in the CHARISMA trial
    • Cacoub, PP, Bhatt, DL, Steg, PG, Topol, EJ, Creager, MA, CHARISMA Investigators. Patients with peripheral arterial disease in the CHARISMA trial. Eur Heart J 30 (2009), 192–201.
    • (2009) Eur Heart J , vol.30 , pp. 192-201
    • Cacoub, P.P.1    Bhatt, D.L.2    Steg, P.G.3    Topol, E.J.4    Creager, M.A.5
  • 12
    • 84876110526 scopus 로고    scopus 로고
    • Vorapaxar in patients with peripheral artery disease: results from TRA2°P-TIMI 50
    • Bonaca, MP, Scirica, BM, Creager, MA, et al. Vorapaxar in patients with peripheral artery disease: results from TRA2°P-TIMI 50. Circulation 127 (2013), 1522–1529.
    • (2013) Circulation , vol.127 , pp. 1522-1529
    • Bonaca, M.P.1    Scirica, B.M.2    Creager, M.A.3
  • 13
    • 84884336961 scopus 로고    scopus 로고
    • Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies
    • Prins, MH, Lensing, AW, Bauersachs, R, et al. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thromb J, 11, 2013, 21.
    • (2013) Thromb J , vol.11 , pp. 21
    • Prins, M.H.1    Lensing, A.W.2    Bauersachs, R.3
  • 14
    • 80052592404 scopus 로고    scopus 로고
    • Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
    • Patel, MR, Mahaffey, KW, Garg, J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365 (2011), 883–891.
    • (2011) N Engl J Med , vol.365 , pp. 883-891
    • Patel, M.R.1    Mahaffey, K.W.2    Garg, J.3
  • 15
    • 45949099359 scopus 로고    scopus 로고
    • Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty
    • Eriksson, BI, Borris, LC, Friedman, RJ, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med 358 (2008), 2765–2775.
    • (2008) N Engl J Med , vol.358 , pp. 2765-2775
    • Eriksson, B.I.1    Borris, L.C.2    Friedman, R.J.3
  • 16
    • 84862907587 scopus 로고    scopus 로고
    • Rivaroxaban in patients with a recent acute coronary syndrome
    • Mega, JL, Braunwald, E, Wiviott, SD, et al. Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med 366 (2012), 9–19.
    • (2012) N Engl J Med , vol.366 , pp. 9-19
    • Mega, J.L.1    Braunwald, E.2    Wiviott, S.D.3
  • 17
    • 85026258046 scopus 로고    scopus 로고
    • Rationale, design and baseline characteristics of participants in the cardiovascular outcomes for people using anticoagulation strategies (COMPASS) trial
    • Bosch, J, Eikelboom, JW, Connolly, SJ, et al. Rationale, design and baseline characteristics of participants in the cardiovascular outcomes for people using anticoagulation strategies (COMPASS) trial. Can J Cardiol 33 (2017), 1027–1035.
    • (2017) Can J Cardiol , vol.33 , pp. 1027-1035
    • Bosch, J.1    Eikelboom, J.W.2    Connolly, S.J.3
  • 18
    • 85029804845 scopus 로고    scopus 로고
    • Rivaroxaban with or without aspirin in stable cardiovascular disease
    • published online Aug 27.
    • Eikelboom, JW, Connolly, SJ, Bosch, J, et al. Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med, 2017 published online Aug 27. DOI:10.1056/NEJMoa1709118.
    • (2017) N Engl J Med
    • Eikelboom, J.W.1    Connolly, S.J.2    Bosch, J.3
  • 19
    • 84999277873 scopus 로고    scopus 로고
    • The conundrum of ALI and systemic embolic events: seeing our way to improved vascular health
    • Hirsch, AT, Van't Hof, JR, Bonaca, M, The conundrum of ALI and systemic embolic events: seeing our way to improved vascular health. Vasc Med 21 (2016), 535–538.
    • (2016) Vasc Med , vol.21 , pp. 535-538
    • Hirsch, A.T.1    Van't Hof, J.R.2    Bonaca, M.3
  • 20
    • 85020892994 scopus 로고    scopus 로고
    • A structured review of antithrombotic therapy in peripheral artery disease with a focus on revascularization: a TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) initiative
    • Hess, CN, Norgren, L, Ansel, GM, et al. A structured review of antithrombotic therapy in peripheral artery disease with a focus on revascularization: a TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) initiative. Circulation 135 (2017), 2534–2555.
    • (2017) Circulation , vol.135 , pp. 2534-2555
    • Hess, C.N.1    Norgren, L.2    Ansel, G.M.3
  • 21
    • 84922393847 scopus 로고    scopus 로고
    • Clinical trials in peripheral vascular disease: pipeline and trial designs: an evaluation of the ClinicalTrials.gov database
    • Subherwal, S, Patel, MR, Chiswell, K, et al. Clinical trials in peripheral vascular disease: pipeline and trial designs: an evaluation of the ClinicalTrials.gov database. Circulation 130 (2014), 1812–1819.
    • (2014) Circulation , vol.130 , pp. 1812-1819
    • Subherwal, S.1    Patel, M.R.2    Chiswell, K.3
  • 22
    • 65549105821 scopus 로고    scopus 로고
    • Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials
    • Berger, JS, Krantz, MJ, Kittelson, JM, Hiatt, WR, Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. JAMA 301 (2009), 1909–1919.
    • (2009) JAMA , vol.301 , pp. 1909-1919
    • Berger, J.S.1    Krantz, M.J.2    Kittelson, J.M.3    Hiatt, W.R.4
  • 23
    • 84978199994 scopus 로고    scopus 로고
    • Ticagrelor for prevention of ischemic events after myocardial infarction in patients with peripheral artery disease
    • Bonaca, MP, Bhatt, DL, Storey, RF, et al. Ticagrelor for prevention of ischemic events after myocardial infarction in patients with peripheral artery disease. J Am Coll Cardiol 67 (2016), 2719–2728.
    • (2016) J Am Coll Cardiol , vol.67 , pp. 2719-2728
    • Bonaca, M.P.1    Bhatt, D.L.2    Storey, R.F.3
  • 24
    • 0000797969 scopus 로고    scopus 로고
    • A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE)
    • CAPRIE Steering Committee. A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet 348 (1996), 329–339.
    • (1996) Lancet , vol.348 , pp. 329-339
  • 25
    • 79960386928 scopus 로고    scopus 로고
    • Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004
    • Pande, RL, Perlstein, TS, Beckman, JA, Creager, MA, Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation 124 (2011), 17–23.
    • (2011) Circulation , vol.124 , pp. 17-23
    • Pande, R.L.1    Perlstein, T.S.2    Beckman, J.A.3    Creager, M.A.4
  • 26
    • 85018445836 scopus 로고    scopus 로고
    • Underuse of prevention and lifestyle counseling in patients with peripheral artery disease
    • Berger, JS, Ladap, JA, Underuse of prevention and lifestyle counseling in patients with peripheral artery disease. J Am Coll Cardiol 69 (2017), 2293–2300.
    • (2017) J Am Coll Cardiol , vol.69 , pp. 2293-2300
    • Berger, J.S.1    Ladap, J.A.2
  • 27
    • 85018315727 scopus 로고    scopus 로고
    • A meta-analysis of long-term mortality and associated risk factors following lower extremity amputation
    • Stern, JR, Wong, CK, Yerovinkina, M, et al. A meta-analysis of long-term mortality and associated risk factors following lower extremity amputation. Ann Vasc Surg 42 (2017), 322–327.
    • (2017) Ann Vasc Surg , vol.42 , pp. 322-327
    • Stern, J.R.1    Wong, C.K.2    Yerovinkina, M.3
  • 28
    • 84904574415 scopus 로고    scopus 로고
    • Lower extremity amputation in peripheral artery disease: improving patient outcomes
    • Swaminathan, A, Vemulapalli, S, Patel, MR, Jones, WS, Lower extremity amputation in peripheral artery disease: improving patient outcomes. Vasc Health Risk Manag 10 (2014), 417–424.
    • (2014) Vasc Health Risk Manag , vol.10 , pp. 417-424
    • Swaminathan, A.1    Vemulapalli, S.2    Patel, M.R.3    Jones, W.S.4
  • 29
    • 85172569058 scopus 로고    scopus 로고
    • Rivaroxaban in stable coronary disease
    • published online Nov 10.
    • Connolly, SJ, Eikelboom, W, Fox, K, et al. Rivaroxaban in stable coronary disease. Lancet, 2017 published online Nov 10. http://dx.doi.org/10.1016/S0140-6736(17)32458-3.
    • (2017) Lancet
    • Connolly, S.J.1    Eikelboom, W.2    Fox, K.3
  • 30
    • 0347086152 scopus 로고    scopus 로고
    • Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease
    • Ostergren, J, Sleight, P, Dagenais, G, et al. Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J 25 (2004), 17–24.
    • (2004) Eur Heart J , vol.25 , pp. 17-24
    • Ostergren, J.1    Sleight, P.2    Dagenais, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.